Salih, Zinnor N.
HRN: 05-56-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFTRIAXONE 1G (VIAL)
09/29/2023
10/05/2023
IV
2g
OD
Infected Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes